Mizuho Gives Healthcare Trust (HTA) Lower Rating; Last Week ArcelorMittal (MT) Coverage

February 20, 2018 - By Winifred Garcia

Among 12 analysts covering Healthcare Trust of America (NYSE:HTA), 10 have Buy rating, 0 Sell and 2 Hold. Therefore 83% are positive. Healthcare Trust of America has $38 highest and $25 lowest target. $33.70’s average target is 26.55% above currents $26.63 stock price. Healthcare Trust of America had 36 analyst reports since August 26, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Thursday, August 25 by BTIG Research. The rating was upgraded by TheStreet to “Buy” on Friday, October 16. The rating was initiated by Morgan Stanley with “Equal-Weight” on Wednesday, December 9. The firm earned “Buy” rating on Thursday, December 31 by Stifel Nicolaus. On Friday, July 7 the stock rating was maintained by Jefferies with “Buy”. The stock of Healthcare Trust of America, Inc. (NYSE:HTA) earned “Buy” rating by Stifel Nicolaus on Wednesday, October 25. The rating was maintained by BMO Capital Markets with “Buy” on Tuesday, July 18. Stifel Nicolaus upgraded Healthcare Trust of America, Inc. (NYSE:HTA) rating on Wednesday, August 26. Stifel Nicolaus has “Buy” rating and $27 target. The rating was maintained by SunTrust with “Buy” on Tuesday, October 24. On Friday, December 16 the stock rating was initiated by Jefferies with “Buy”.

Among 17 analysts covering Arcelormittal (NYSE:MT), 13 have Buy rating, 1 Sell and 3 Hold. Therefore 76% are positive. Arcelormittal had 54 analyst reports since July 21, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Monday, October 5 by Citigroup. ING Group upgraded ArcelorMittal (NYSE:MT) on Friday, July 14 to “Buy” rating. On Tuesday, February 9 the stock rating was upgraded by Goldman Sachs to “Neutral”. The firm earned “Sector Perform” rating on Friday, December 18 by RBC Capital Markets. Cowen & Co maintained it with “Hold” rating and $32.0 target in Monday, November 13 report. The firm earned “Buy” rating on Wednesday, August 30 by Jefferies. Jefferies maintained ArcelorMittal (NYSE:MT) on Tuesday, July 18 with “Buy” rating. On Friday, August 19 the stock rating was upgraded by JP Morgan to “Neutral”. As per Tuesday, June 6, the company rating was downgraded by Bank of America. Cowen & Co upgraded it to “Outperform” rating and $11 target in Thursday, March 23 report. See ArcelorMittal (NYSE:MT) latest ratings:

26/01/2018 Broker: J.P. Morgan Rating: Buy
10/01/2018 Broker: Bank of America Rating: Hold Upgrade
09/01/2018 Broker: Jefferies Rating: Buy New Target: $42.0 Maintain
04/01/2018 Broker: Cowen & Co Rating: Hold New Target: $35.0 Maintain
13/11/2017 Broker: Cowen & Co Rating: Hold New Target: $32.0 Maintain
24/10/2017 Broker: Cowen & Co Rating: Hold New Target: $27.0 Maintain
24/10/2017 Broker: Jefferies Rating: Buy New Target: $37.0 Maintain
22/09/2017 Broker: Cowen & Co Old Rating: Outperform New Rating: Market Perform Downgrade
30/08/2017 Broker: Jefferies Rating: Buy New Target: $34.0 Maintain
23/08/2017 Broker: Cowen & Co Rating: Buy New Target: $32.0 Maintain

The stock increased 2.62% or $0.68 during the last trading session, reaching $26.63. About 1.59M shares traded or 27.20% up from the average. Healthcare Trust of America, Inc. (NYSE:HTA) has risen 7.80% since February 20, 2017 and is uptrending. It has underperformed by 8.90% the S&P500.

Healthcare Trust of America, Inc. is the largest dedicated owner and operator of medical office buildings ("MOBs") in the United States based on gross leasable area ("GLA"). The company has market cap of $5.57 billion. We provide the real estate infrastructure for the integrated delivery of healthcare services in highly desirable locations. It has a 78.32 P/E ratio. Over the last decade, we have invested $7.0 billion primarily in MOBs and other healthcare assets comprising 24.2 million square feet of GLA.

Analysts await Healthcare Trust of America, Inc. (NYSE:HTA) to report earnings on February, 21. They expect $0.42 EPS, 0.00% or $0.00 from last year’s $0.42 per share. HTA’s profit will be $87.77M for 15.85 P/E if the $0.42 EPS becomes a reality. After $0.42 actual EPS reported by Healthcare Trust of America, Inc. for the previous quarter, Wall Street now forecasts 0.00% EPS growth.

ArcelorMittal, together with its subsidiaries, owns and operates steel manufacturing and mining facilities. The company has market cap of $34.64 billion. The firm operates through five divisions: NAFTA, Brazil, Europe, ACIS, and Mining. It has a 8.18 P/E ratio. It produces finished and semi-finished steel products with various specifications.

The stock increased 3.37% or $1.19 during the last trading session, reaching $36.48. About 7.08M shares traded or 103.52% up from the average. ArcelorMittal (NYSE:MT) has risen 67.93% since February 20, 2017 and is uptrending. It has outperformed by 51.23% the S&P500.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>